Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
5,848
Views
15
CrossRef citations to date
0
Altmetric
Oncology
Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer
Julie Vanderpoela Janssen Scientific Affairs, LLC, Horsham, PA, USAhttps://orcid.org/0000-0001-5055-6216
, Andrea L. Stevensb Janssen Global Services, Inc, Raritan, NJ, USAhttps://orcid.org/0000-0002-2892-7065
, Bruno Emondc Analysis Group, Inc, Montréal, Québec, Canadahttps://orcid.org/0000-0002-0060-765X
, Marie-Hélène Lafeuillec Analysis Group, Inc, Montréal, Québec, Canada
, Annalise Hiltsc Analysis Group, Inc, Montréal, Québec, Canada
, Patrick Lefebvrec Analysis Group, Inc, Montréal, Québec, Canada
& Laura Morrisonc Analysis Group, Inc, Montréal, Québec, CanadaCorrespondence[email protected]
show all
Pages 457-468
|
Received 10 Feb 2022, Accepted 11 Mar 2022, Published online: 30 Mar 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.